NCT00614367

Brief Summary

Optimise genetic screening of human embryos using higher resolution techniques

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2005

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2005

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

January 30, 2008

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 13, 2008

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
Last Updated

February 13, 2008

Status Verified

January 1, 2008

Enrollment Period

2.4 years

First QC Date

January 30, 2008

Last Update Submit

February 11, 2008

Conditions

Chromosomal Abnormalities

Keywords

chromosomal abnormalities in single cells

Outcome Measures

Primary Outcomes (1)

  • genetic constitution of single blastomeres

    3 day old embryos

Eligibility Criteria

Age3 Days - 4 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

3-4 day old human IVF embryos

You may qualify if:

  • day old embryos from IVF couples with both partners younger than 36 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Leuven, Catholic University Leuven

Leuven, 3000, Belgium

Location

Biospecimen

Retention: SAMPLES WITH DNA

Single blastomeres of human embryos

MeSH Terms

Conditions

Chromosome Aberrations

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Joris Vermeesch, Prof PhD

    University Hospital Leuven, Catholic University Leuven

    PRINCIPAL INVESTIGATOR

  • Thomas D'hooghe, Prof MD PhD

    Universitaire Ziekenhuizen KU Leuven

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 30, 2008

First Posted

February 13, 2008

Study Start

October 1, 2005

Primary Completion

March 1, 2008

Study Completion

June 1, 2008

Last Updated

February 13, 2008

Record last verified: 2008-01

Locations

BE(1)